Bausch & Lomb Corp
BLCONYSECIK 1860742HealthcareFiscal year ends Dec 31
Reports and events: 84 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2816:39 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-436254 |
| 2026-10-2816:25 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001860742-26-000111 |
| 2026-10-2807:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-26-000108 |
| 2026-10-1306:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-26-015460 |
| 2026-08-1207:01 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000950103-26-012223 |
| 2026-08-0607:10 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-26-011979 |
| 2026-07-2916:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001860742-26-000088 |
| 2026-07-2907:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-26-000086 |
| 2026-05-2016:32 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-232712 |
| 2026-04-2916:36 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001860742-26-000062 |
| 2026-04-2907:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-26-000060 |
| 2026-04-1016:05 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0001140361-26-014234 |
| 2026-02-1817:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001860742-26-000007 |
| 2026-02-1807:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-26-000006 |
| 2026-01-0216:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-26-000051 |
| 2025-12-2216:10 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001860742-25-000035 |
| 2025-12-1716:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-322866 |
| 2025-12-1217:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-016088 |
| 2025-11-1307:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-25-014656 |
| 2025-10-2916:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001860742-25-000023 |
| 2025-10-2907:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-25-000021 |
| 2025-08-1817:06 ET | 8-K | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001860742-25-000019 |
| 2025-07-3017:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001860742-25-000018 |
| 2025-07-3007:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-25-000016 |
| 2025-07-2316:56 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950103-25-009183 |
| 2025-06-2707:33 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-149726 |
| 2025-06-1816:52 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007603 |
| 2025-06-1009:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007189 |
| 2025-05-2116:36 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-124034 |
| 2025-05-2119:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-006266 |
| 2025-04-3016:17 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001860742-25-000008 |
| 2025-04-3007:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-25-000007 |
| 2025-04-1016:02 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001140361-25-013244 |
| 2025-02-1916:47 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001860742-25-000004 |
| 2025-02-1907:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-25-000003 |
| 2024-11-0116:27 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950103-24-015809 |
| 2024-10-3016:32 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001860742-24-000018 |
| 2024-10-3007:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-24-000016 |
| 2024-08-0116:17 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001860742-24-000014 |
| 2024-07-3107:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-24-000011 |
| 2024-05-2916:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-149259 |
| 2024-05-0116:47 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001860742-24-000008 |
| 2024-05-0107:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-24-000007 |
| 2024-04-2916:06 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0001308179-24-000628 |
| 2024-02-2808:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-049266 |
| 2024-02-2116:55 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001860742-24-000004 |
| 2024-02-2107:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001860742-24-000003 |
| 2023-11-1316:47 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-23-276133 |
| 2023-11-0717:00 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001860742-23-000032 |
| 2023-11-0117:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001860742-23-000029 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:28 ET. Listed shows no prices and gives no investment advice.